⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28159469 | 0.84 | KDM4E (0.31) | — | |
| Sorbitol SCHEMBL10995011 | 0.82 | LMNA (0.39) | — | |
| SCHEMBL6887926 | 0.81 | — | — | |
| SCHEMBL1040932 | 0.77 | — | — | |
| SCHEMBL7109838 | 0.77 | — | — | |
| SCHEMBL6427762 | 0.76 | — | — | |
| SCHEMBL253162 | 0.75 | — | — | |
| SCHEMBL175854 | 0.75 | — | — | |
| SCHEMBL28386948 | 0.73 | — | — | |
| SCHEMBL6310315 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 213 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180099953-A1 | BENZOFURANS SUBSTITUTED WITH SECONDARY BENZAMIDE AS HCV INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2018-04-12 | — | — | US | claimed |
| US-20180030019-A1 | SUBSTITUTED BENZOFURAN COMPOUNDS FOR THE TREATMENT OF HEPATITIS C | BRISTOL MYERS SQUIBB CO (US) | 2018-02-01 | — | — | US | claimed |
| US-20180030017-A1 | BENZOFURANS SUBSTITUTED WITH PRIMARY BENZAMIDE AS HCV INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2018-02-01 | — | — | US | claimed |
| US-20180030056-A1 | BENZOFURANS SUBSTITUTED WITH BICYCLIC SECONDARY BENZAMIDE AS HCV INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2018-02-01 | — | — | US | claimed |
| EP-2831066-B1 | BENZOFURAN DERIVATIVES FOR THE TREATMENT OF HEPATITIS C | BRISTOL MYERS SQUIBB CO (US) | 2016-10-05 | — | — | EP | claimed |
| WO-2016133963-A1 | BENZOFURANS SUBSTITUTED WITH SECONDARY BENZAMIDE AS HCV INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2016-08-25 | — | — | WO | claimed |
| WO-2016133972-A1 | SUBSTITUTED BENZOFURAN COMPOUNDS FOR THE TREATMENT OF HEPATITIS C | BRISTOL-MYERS SQUIBB COMPANY (US) | 2016-08-25 | — | — | WO | claimed |
| WO-2016133961-A1 | BENZOFURANS SUBSTITUTED WITH BICYCLIC SECONDARY BENZAMIDE AS HCV INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2016-08-25 | — | — | WO | claimed |
| WO-2016133970-A1 | BENZOFURANS SUBSTITUTED WITH PRIMARY BENZAMIDE AS HCV INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2016-08-25 | — | — | WO | claimed |
| US-9096580-B2 | Benzofuran derivatives for the treatment of hepatitis C | BRISTOL-MYERS SQUIBB COMPANY (US) | 2015-08-04 | — | — | US | claimed |
| EP-1630157-A1 | CaSR ANTAGONIST | JAPAN TOBACCO INC. (JP) | 2006-03-01 | — | — | EP | claimed |
| US-20050227978-A1 | Fibrosis inhibitor | SUMITOMO PHARMACEUTICALS CO., LTD. (JP) | 2005-10-13 | — | — | US | claimed |
| US-20050032786-A1 | 1, 3-benzothiazinone derivatives and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2005-02-10 | — | — | US | claimed |
| EP-1424336-A1 | 1,3-BENZOTHIAZINONE DERIVATIVES AND USE THEREOF | Takeda Chemical Industries, Ltd. (JP) | 2004-06-02 | — | — | EP | claimed |
| EP-1278413-A2 | N-ARYL-URACILE-BASED HERBICIDES | Bayer CropScience AG (DE) | 2003-01-29 | — | — | EP | claimed |
| WO-2001039597-A2 | N-ARYL-URACILE-BASED HERBICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2001-06-07 | — | — | WO | claimed |
| EP-1049376-A1 | SELECTIVE HERBICIDES BASED ON N-ARYL- TRIAZOLINE(THI)ONS AND N-ARLYSULFONYLAMINO (THIO)CARBONYL- TRIAZOLINE(THI) ONS | Bayer Aktiengesellschaft (DE) | 2000-11-08 | — | — | EP | claimed |
| WO-1999037153-A1 | SELECTIVE HERBICIDES BASED ON N-ARYL- TRIAZOLINE(THI)ONS AND N-ARLYSULFONYLAMINO (THIO)CARBONYL- TRIAZOLINE(THI) ONS | BAYER AKTIENGESELLSCHAFT (DE) | 1999-07-29 | — | — | WO | claimed |
| WO-1998027088-A1 | HETEROCYCLYLURACILS | BAYER AKTIENGESELLSCHAFT (DE) | 1998-06-25 | — | — | WO | claimed |
| US-4978672-A | Alpha-heterocyclc substituted tolunitriles | CIBA-GEIGY CORPORATION (US) | 1990-12-18 | — | — | US | claimed |